Return On Assets of Protara Therapeutics, Inc. from 30 Jun 2015 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Protara Therapeutics, Inc. quarterly and annual Return On Assets in % history and change rate from 30 Jun 2015 to 30 Sep 2025.
  • Protara Therapeutics, Inc. Return On Assets for the quarter ending 30 Sep 2025 was -32%, a 34% increase year-over-year.
  • Protara Therapeutics, Inc. annual Return On Assets for 2024 was -40%, a 8.6% increase from 2023.
  • Protara Therapeutics, Inc. annual Return On Assets for 2023 was -44%, a 4% increase from 2022.
  • Protara Therapeutics, Inc. annual Return On Assets for 2022 was -46%, a 77% decline from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

Protara Therapeutics, Inc. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -32% +17% +34% 01 Jul 2025 30 Sep 2025
Q2 2025 -34% +14% +30% 01 Apr 2025 30 Jun 2025
Q1 2025 -33% +18% +35% 01 Jan 2025 31 Mar 2025
Q4 2024 -40% +4% +8.6% 01 Oct 2024 31 Dec 2024
Q3 2024 -49% +20% +28% 01 Jul 2024 30 Sep 2024
Q2 2024 -48% +10% +17% 01 Apr 2024 30 Jun 2024
Q1 2024 -51% -2% -4.6% 01 Jan 2024 31 Mar 2024
Q4 2023 -44% +2% +4% 01 Oct 2023 31 Dec 2023
Q3 2023 -69% -45% -194% 01 Jul 2023 30 Sep 2023
Q2 2023 -58% -34% -140% 01 Apr 2023 30 Jun 2023
Q1 2023 -49% -24% -94% 01 Jan 2023 31 Mar 2023
Q4 2022 -46% -20% -77% 01 Oct 2022 31 Dec 2022
Q3 2022 -23% +1% +2.5% 01 Jul 2022 30 Sep 2022
Q2 2022 -24% -2% -9.6% 01 Apr 2022 30 Jun 2022
Q1 2022 -25% -3% -11% 01 Jan 2022 31 Mar 2022
Q4 2021 -26% 0% -1.4% 01 Oct 2021 31 Dec 2021
Q3 2021 -24% +9% +28% 01 Jul 2021 30 Sep 2021
Q2 2021 -22% +39% +64% 01 Apr 2021 30 Jun 2021
Q1 2021 -23% +48% +68% 01 Jan 2021 31 Mar 2021
Q4 2020 -25% +52% +67% 01 Oct 2020 31 Dec 2020
Q3 2020 -33% +34% +51% 01 Jul 2020 30 Sep 2020
Q2 2020 -61% +2% +3.1% 01 Apr 2020 30 Jun 2020
Q1 2020 -71% -4% -5.8% 01 Jan 2020 31 Mar 2020
Q4 2019 -77% -7% -9.3% 01 Oct 2019 31 Dec 2019
Q3 2019 -67% -6% -10% 01 Jul 2019 30 Sep 2019
Q2 2019 -63% +9% +13% 01 Apr 2019 30 Jun 2019
Q1 2019 -67% +5% +6.9% 01 Jan 2019 31 Mar 2019
Q4 2018 -71% +3% +4.3% 01 Oct 2018 31 Dec 2018
Q3 2018 -61% +17% +21% 01 Jul 2018 30 Sep 2018
Q2 2018 -73% -8% -13% 01 Apr 2018 30 Jun 2018
Q1 2018 -72% -10% -16% 01 Jan 2018 31 Mar 2018
Q4 2017 -74% -20% -36% 01 Oct 2017 31 Dec 2017
Q3 2017 -78% -30% -63% 01 Jul 2017 30 Sep 2017
Q2 2017 -64% -24% -58% 01 Apr 2017 30 Jun 2017
Q1 2017 -62% -28% -83% 01 Jan 2017 31 Mar 2017
Q4 2016 -54% -26% -89% 01 Oct 2016 31 Dec 2016
Q3 2016 -48% -38% -381% 01 Jul 2016 30 Sep 2016
Q2 2016 -41% -29% -257% 01 Apr 2016 30 Jun 2016
Q1 2016 -34% 01 Jan 2016 31 Mar 2016
Q4 2015 -29% 01 Oct 2015 31 Dec 2015
Q3 2015 -10% 01 Jul 2015 30 Sep 2015
Q2 2015 -11% 01 Apr 2015 30 Jun 2015

Protara Therapeutics, Inc. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2024 -40% +4% +8.6% 01 Jan 2024 31 Dec 2024
2023 -44% +2% +4% 01 Jan 2023 31 Dec 2023
2022 -46% -20% -77% 01 Jan 2022 31 Dec 2022
2021 -26% 0% -1.4% 01 Jan 2021 31 Dec 2021
2020 -25% +52% +67% 01 Jan 2020 31 Dec 2020
2019 -77% -7% -9.3% 01 Jan 2019 31 Dec 2019
2018 -71% +3% +4.3% 01 Jan 2018 31 Dec 2018
2017 -74% -20% -36% 01 Jan 2017 31 Dec 2017
2016 -54% -26% -89% 01 Jan 2016 31 Dec 2016
2015 -29% 01 Jan 2015 31 Dec 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.